Alps Advisors Inc Merck & Co., Inc. Transaction History

Alps Advisors Inc

$14.1 Billion
Q1 2024

A detailed history of Alps Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 109,601 shares of MRK stock, worth $13.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

109,601

Previous 108,774 0.76%

Holding current value

$13.6 Million

Previous $11.9 Million 21.95%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $93,649 - $109,122	827 Added 0.76%	109,601 $14.5 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $40,072 - $43,608	-400 Reduced 0.37%	108,774 $11.9 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $16.2 Million - $18 Million	-157,403 Reduced 59.05%	109,174 $11.2 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.16 Million - $1.26 Million	-10,659 Reduced 3.84%	266,577 $30.8 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $1.8 Million - $2.01 Million	-17,500 Reduced 5.94%	277,236 $29.5 Million

Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $1.79 Million - $2.3 Million	-20,482 Reduced 6.5%	294,736 $32.7 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $7.94 Million - $8.92 Million	93,903 Added 42.43%	315,218 $27.1 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $14.1 Million - $16 Million	168,865 Added 321.95%	221,315 $20.2 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $8,821 - $9,888	-120 Reduced 0.23%	52,450 $4.3 Million
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $21 Million - $26.3 Million	-290,481 Reduced 84.68%	52,570 $4.03 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $1.49 Million - $1.64 Million	-20,855 Reduced 5.73%	343,051 $25.8 Million
Q2 2021 Aug 11, 2021	BUY	$70.31 - $77.77 $1.28 Million - $1.42 Million	18,232 Added 5.27%	363,906 $28.3 Million
Q1 2021 May 07, 2021	BUY	$68.86 - $81.11 $3.95 Million - $4.66 Million	57,411 Added 19.92%	345,674 $26.6 Million
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $17.6 Million - $19.5 Million	245,385 Added 572.29%	288,263 $23.6 Million
Q3 2020 Nov 04, 2020	BUY	$73.18 - $82.95 $657,302 - $745,056	8,982 Added 26.5%	42,878 $3.56 Million
Q2 2020 Aug 05, 2020	BUY	$70.42 - $80.13 $950,740 - $1.08 Million	13,501 Added 66.2%	33,896 $2.62 Million
Q1 2020 May 06, 2020	SELL	$63.36 - $87.82 $665,089 - $921,846	-10,497 Reduced 33.98%	20,395 $1.57 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $113,189 - $127,720	-1,459 Reduced 4.51%	30,892 $2.81 Million
Q3 2019 Nov 04, 2019	SELL	$76.08 - $82.93 $465,533 - $507,448	-6,119 Reduced 15.91%	32,351 $2.72 Million
Q2 2019 Aug 07, 2019	BUY	$69.84 - $81.59 $368,266 - $430,224	5,273 Added 15.88%	38,470 $3.23 Million
Q1 2019 May 01, 2019	BUY	$69.58 - $79.36 $44,113 - $50,314	634 Added 1.95%	33,197 $2.76 Million
Q4 2018 Feb 04, 2019	SELL	$65.24 - $75.71 $42.1 Million - $48.9 Million	-645,297 Reduced 95.2%	32,563 $2.49 Million
Q3 2018 Oct 25, 2018	SELL	$57.69 - $67.84 $4.34 Million - $5.11 Million	-75,296 Reduced 10.0%	677,860 $48.1 Million
Q2 2018 Aug 02, 2018	SELL	$50.83 - $59.72 $6.09 Million - $7.16 Million	-119,903 Reduced 13.73%	753,156 $45.7 Million
Q2 2018 Jul 25, 2018	SELL	$50.83 - $59.72 $475,972 - $559,218	-9,364 Reduced 1.06%	873,059 $49.1 Million
Q1 2018 May 01, 2018	BUY	$50.96 - $59.23 $477,189 - $554,629	9,364 Added 1.07%	882,423 $48.1 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $8.6 Million - $10.3 Million	166,602 Added 23.58%	873,059 $49.1 Million
Q3 2017 Nov 03, 2017	BUY	$58.67 - $63.13 $41.4 Million - $44.6 Million	706,457	706,457 $45.2 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Merck & Co., Inc. Transaction History